Annovis Bio Inc. (ANVS) Social Stream



Annovis Bio Inc. (ANVS): $12.64

0.48 (+3.95%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

ANNOVIS BIO INC (ANVS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ANNOVIS BIO INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 1 $70 $70 $70 $12.25 471.43%
2022-04-08 1 $26 $26 $26 $12.25 112.24%
2022-08-09 2 $37 $26 $31.5 $12.25 157.14%
2023-04-04 3 $72 $26 $46 $12.25 275.51%
2023-10-13 3 $72 $40 $56 $12.25 357.14%
2023-10-20 4 $72 $26.001 $46 $12.25 275.51%
2023-11-13 5 $72 $26.001 $40.75 $12.25 232.65%

Price Target Last Issued April 8, 2022

The Trend in the Analyst Price Target


Over the past 41 months, ANVS's average price target has gone up $24.75.

Over the past 41 weeks, ANVS's average upside potential has been 368.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-21 2 72 40 56 15.81 254.21%
2023-06-28 2 72 40 56 14.16 295.48%
2023-08-15 2 72 40 56 12.83 336.48%
2023-08-17 2 72 40 56 12.77 338.53%
2023-10-13 2 72 40 56 7.86 612.47%

ANVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


ANVS's average broker recommendation rating improved by 0 over the prior 52 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 77.65% of that group.
  • ANVS has a greater upside potential (average analyst target price relative to current price) than 971.97% of all US stocks.
  • In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -521.08% of that group.
  • ANNOVIS BIO INC's average analyst price target is higher than 928.36% of stocks in the small market cap category.

Stocks similar to ANNOVIS BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, GRTX, and PHAT.

What is the outlook for ANVS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!